About Repromed

Repromed Diagnostic (P) Limited was instituted almost three decades back to provide diagnostic laboratory facilities of international standard in the eastern part of our country.

Repromed Diagnostic (P) Limited was instituted almost three decades back to provide diagnostic laboratory facilities of international standard in the eastern part of our country.  By now the laboratory has achieved a distinct distinction in that respect. However, most rewarding of all is the recognition of the effect of our laboratory diagnosis on patient care. An appreciation for this impact carries with it a profound sense of obligation that prompts us to emphasize the importance of “getting it right.” The face of the discipline of clinical medicine has been changing dramatically. Continued research effort has been credited with new insights into the process of disease development and isolation of newer pathological markers on one hand and innovation of novel diagnostic tools with full automation on the other. This accelerated pace of change is challenging to cope with, particularly in a developing country like ours. However, it has been our persistent endeavour to make available all the globally appraised state-of-the-art technologies at your doorstep to provide extended power for diagnosis. As a part of that endeavour, we have expanded our laboratory set-up in an ultramodern orientation. We believe, we have so far stayed true to our objective, and constant patronage from the doctors and patients would help us dedicate our continued effort for further improvement of patient care.


Broaden the spectrum of diagnostic laboratory services while implementing state-of-the-art technologies and setting a new benchmark for quality standards that would shape the future of the art of diagnosis. Seek innovative ways to enhance patient care empowering health and impacting lives, and become the role model in supporting high-quality health care by offering cost-effective and innovative laboratory services. Encourage the highest level of competence, accountability, and technical excellence in the provision of diagnostic laboratory services.


To be the best at what we commit for continuous improvement of laboratory services in a manner that reflects a total commitment to today’s most exacting standards.

To provide every patient with reliable and timely services of uncompromising quality for the benefits surpassing their expectations.

To dedicate ourselves to the relentless pursuit of excellence and become an acclaimed leader and voice for diagnostic laboratory services in the regional healthcare system.

Dr. Syed N Kabir

Dr. Syed N Kabir is an eminent Reproductive Biologist. Before joining Repromed Diagnostic Private Limited, Dr. Kabir served CSIR-Indian Institute of Chemical Biology under the aegis of Ministry of Science & Technology, Government of India as a Chief Scientist. His domain of research encompasses broad areas of female infertility and contraception. He has made a significant contribution to the understanding of the basic tenets of endometriosis, premature ovarian failure, and metabolic aspects of polycystic ovary syndrome. He was also instrumental in developing and optimizing the stimulation protocols for assisted reproductive techniques in the Institute of Reproductive Medicine, Kolkata. His contribution in this direction earned him the Federation of Obstetrics and Gynecology award in Reproductive Endocrinology in 2007. Dr. Kabir served as Chairman of the Consortium Advisory Committee of ICAR and Member of the Domain Expert Group of CSIR and ICMR engaged in implementing and monitoring different research proposals on Reproductive Health in India.


Prof. Siddhartha Roy

Prof. Siddhartha Roy obtained his Ph.D. from the University of Delaware and did his post-doctoral training at Brandeis University and National Institutes of Health. In 2004, he became the Director of CSIR-Indian Institute of Chemical Biology (2004-2014). In parallel, he founded NIPER-Kolkata (an institute of National Importance created by an act of Parliament) in 2007 and held the additional charge of the institute as the founding Director-in-charge (2007-2014). He was also a Visiting Scientist, NIH, USA and a Visiting Professor, Osaka University, Japan. He was the Founder-President of the Chemical Biology Society (India), a member of the Asian Chemical Biology Initiative (Japan) and a member of the Governing Board of Directors of International Chemical Biology Society.

He made important scientific contributions in gene regulation, drug discovery and analytical techniques. He received many honors, including Bhatnagar Prize, JC Bose National Fellowship, Fellowship of the Royal Society of Chemistry, U.K., Fellowships of two premier National Science Academies in India, FNA and FASc. and Fellowship of the The World Academy of Sciences (Trieste), FTWAS. He was a recipient of Meritorious service award from the Department of Health and Human Services, USA, IUBMB Woods-Whelan Fellowship, and Human Frontier Sciences Fellowship. He has served in the editorial boards of many international journals including Molecular Pharmacology and ACS Chemical Biology.

Dr. Kunal Ray

Dr. Kunal Ray did his PhD in biochemistry from Bose Institute, Kolkata, India. He moved to USA and worked at (i) University of Pennsylvania and (ii) Cornell University. On returning to India in 1998, he joined CSIR-Indian Institute of Chemical Biology (IICB), led Human Genetics division and pursued his research interest primarily in Ocular and Neurological diseases. He has been one of the leaders in pan-Indian effort to identify medically relevant variations in 1000 medically important genes across all the populations of India. He has almost 200 research publications in his credit. On superannuation from IICB in 2012 as a Chief Scientist, he helped to develop Academy of Scientific and Innovative Research (AcSIR), an Institute of national importance, from 2013 to 2017 first as an Associate Director and then as Director (Acting) of the Academy. Currently he is serving as one of the Directors of ATGC Diagnostics Pvt Ltd., Kolkata.

Prof. Nitai Bhattacharyya

Prof. Nitai Bhattacharyya on completion of his PhD degree in Physics from Saha Institute of Nuclear Physics (SINP), Calcutta, India in 1986, he moved to USA as Post-doctoral fellow and worked at (i) Carcinogenesis Laboratory, Michigan State University,(ii) Imperial Cancer Research Fund (London), and (iii) University of Utah, Salt Lake City, USA. On returning to India, he joined SINP in 1994 and superannuated in 2016 as a Senior Professor. He was engaged as the Director of BioMedical Genomics Centre at PG Polyclinics, SSKM Hospital, Kolkata. Professor Bhattacharyya has made sustained contributions on understanding several neurological diseases like Myotonic dystrophy, Huntington’s disease (HD), various subtypes of Spinocerebellar ataxia, Dentatorubral-Pallidoluysian atrophy and Friedreich’s Ataxia. Presently, he is actively engaged in identifying known mutations in several mitochondrial diseases, maturity-onset diabetes of the young, and Bardet-Biedl syndrome in collaboration with clinical researchers in the Institute of Post Graduate Medical Education and Research.